ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 880,28
0,55%
Dow Jones
44 156,73
0,00%
DAX
21 330,79
0,34%
Brent Oil
78,535
0,26%
Bitcoin
102 262,59
-1,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Hepion Pharmaceuticals Inc (PK) (CTRVP)

  7. Hepion Pharmaceuticals Inc (PK) (CTRVP) Actualités

CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:CTRVP
DateHeureSourceTitreSymboleSociété
23/01/202512h03Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
22/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
22/01/202503h56Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
15/01/202522h15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/01/202515h19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/12/202423h22Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/11/202422h52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/11/202422h07Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
05/09/202412h36Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
15/07/202423h17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/03/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
06/03/202422h30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/10/202323h22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/10/202322h52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/07/202323h12Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/05/202322h19Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/04/202322h52Edgar (US Regulatory)Annual Report (10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/04/202312h02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
21/11/202223h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/11/202223h21Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/11/202212h07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/07/202222h06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
05/07/202214h34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/02/202212h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/11/202112h09Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
19/11/202123h01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
21/05/202101h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
28/04/202123h14Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
24/02/202116h48Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
16/02/202123h20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:CTRVP

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
RNO
Renault
EU
BN
Danone
EU
LR
Legrand
EU
DG
Vinci
EU
ORA
Orange
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
COIN
XRPUSD
Ripple
NASDAQ
AAPL
Apple
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
ML
Michelin
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés